APA

Bron S., Henry L., Faes-Van't Hull E., Turrini R., Vanhecke D., Guex N., Ifticene-Treboux A., Marina Iancu E., Semilietof A., Rufer N., Lehr H., Xenarios I., Coukos G., Delaloye J. & Doucey M. (2016). TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer. : Oncoimmunology.

Chicago

Bron Sylvian, Henry Luc, Faes-Van't Hull Eveline, Turrini Riccardo, Vanhecke Dominique, Guex Nicolas, Ifticene-Treboux Assia, Marina Iancu Emanuela, Semilietof Aikaterini, Rufer Nathalie, Lehr Hans-Anton, Xenarios Ioannis, Coukos George, Delaloye Jean-François and Doucey Marie-Agnès. 2016. TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer. : Oncoimmunology.

Harvard

Bron S., Henry L., Faes-Van't Hull E., Turrini R., Vanhecke D., Guex N., Ifticene-Treboux A., Marina Iancu E., Semilietof A., Rufer N., Lehr H., Xenarios I., Coukos G., Delaloye J. and Doucey M. (2016). TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer. : Oncoimmunology.

MLA

Bron Sylvian, Henry Luc, Faes-Van't Hull Eveline, Turrini Riccardo, Vanhecke Dominique, Guex Nicolas, Ifticene-Treboux Assia, Marina Iancu Emanuela, Semilietof Aikaterini, Rufer Nathalie, Lehr Hans-Anton, Xenarios Ioannis, Coukos George, Delaloye Jean-François and Doucey Marie-Agnès. TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer. : Oncoimmunology. 2016.